Dr Reddys (RDY) director Leo Puri submits initial Form 3 insider report

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD director Leo Puri has filed an initial insider ownership report on Form 3. This filing establishes his status as a reporting insider of the company but does not list any specific transactions, focusing instead on baseline disclosure and compliance with insider reporting rules.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

PURI LEO

(Last) (First) (Middle)

501, BELMONT, 37-D,

L.JAGMOHANDAS MARG, NAPEAN SEA ROAD

(Street)

MUMBAI MAHARASHTRA 400036

(City) (State) (Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ LEO PURI	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the DR REDDYS (RDY) Form 3 filing for Leo Puri show?

The Form 3 filing shows that Leo Puri is a director and therefore an insider of DR REDDYS LABORATORIES LTD. It serves as his initial ownership report and confirms his obligation to report future trades in company securities.

Does the RDY Form 3 for Leo Puri disclose any share transactions?

The Form 3 for Leo Puri does not disclose any share transactions. It is an initial insider ownership filing with no reported buys, sells, exercises, gifts, or other trades in DR REDDYS LABORATORIES LTD securities at this time.

Why is Leo Puri considered an insider of DR REDDYS LABORATORIES LTD?

Leo Puri is considered an insider because he is identified as a director of DR REDDYS LABORATORIES LTD. Directors, officers, and certain large shareholders must file Forms 3, 4, and 5 to report their beneficial ownership and changes in that ownership.

What is the purpose of a Form 3 filing for DR REDDYS (RDY)?

A Form 3 filing establishes an insider’s initial beneficial ownership position in DR REDDYS LABORATORIES LTD. It is the starting point for future reporting of trades and changes in ownership, providing transparency around director and officer holdings for investors.

Does the Leo Puri Form 3 mention any derivative securities for RDY?

The insider data summary shows no derivative transactions or remaining derivative positions for Leo Puri. This means the filing does not list options, warrants, or other derivative securities tied to DR REDDYS LABORATORIES LTD for this reporting person.